Moderna also hopes that combining the shots will help improve vaccine rates. Poland, however, is not sure people will like ...

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the ...

In a study published in the Journal of the American Medical Association, researchers from Moderna reported that the new combo ...

Moderna on Thursday reported first-quarter profit and sales that beat Wall Street estimates, helped by the company's ...

MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...

Momentum is building to scale back the current recommendation that all children over 6 months old get immunized against the ...

Moderna is deprioritizing its flu/COVID combination vaccine in younger adults amid a push to cut about $1.5 billion from its ...

The Cambridge-based biotech company has been trying to reduce operating expenses as it burns cash on its large pipeline.

Jefferies analysts said Moderna’s first quarter was “in line,” with a miss on revenue offset by a beat on earnings per share.

Moderna logged a first-quarter loss as revenue fell, dragged down by lower product sales, though the company said it expects ...

The S&P 500 slipped 0.8% on Tuesday, May 6, 2025, falling for a second straight day as investors awaited news on U.S. tariff ...